Cargando…

PFKFB4 as a promising biomarker to predict a poor prognosis in patients with gastric cancer

Gastric cancer (GC) is one of the most common types of cancer worldwide. Previous studies have reported that phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4) functions as an oncoprotein in various types of cancer. However, the association between PFKFB4 and GC remains unclear. The presen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Fang, Wu, Xiaoting, Li, Yajun, Cao, Xiangmei, Zhang, Cao, Gao, Yujing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905623/ https://www.ncbi.nlm.nih.gov/pubmed/33732372 http://dx.doi.org/10.3892/ol.2021.12557

Ejemplares similares

High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer
por: Yao, Ling, et al.
Publicado: (2019)

PFKFB4 Overexpression Facilitates Proliferation by Promoting the G1/S Transition and Is Associated with a Poor Prognosis in Triple-Negative Breast Cancer
por: Cai, Yu-Chen, et al.
Publicado: (2021)

Effect of PFKFB4 on the Prognosis and Immune Regulation of NSCLC and Its Mechanism
por: Zhou, Yong, et al.
Publicado: (2022)

Noncoding RNA-Mediated High Expression of PFKFB3 Correlates with Poor Prognosis and Tumor Immune Infiltration of Lung Adenocarcinoma
por: Gu, Xue, et al.
Publicado: (2023)

Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions
por: Okabe, Seiichi, et al.
Publicado: (2022)

TBL1XR1 Is Highly Expressed in Gastric Cancer and Predicts Poor Prognosis
por: Liu, Fang, et al.
Publicado: (2016)

MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection
por: Sakamoto, Naoko, et al.
Publicado: (2017)

The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue
por: Li, Ximing, et al.
Publicado: (2020)

Differential roles of highly expressed PFKFB4 in colon adenocarcinoma patients
por: Gu, Xiaojing, et al.
Publicado: (2023)

Low FAT4 expression is associated with a poor prognosis in gastric cancer patients
por: Jiang, Xiaoting, et al.
Publicado: (2017)

ULK1: A Promising Biomarker in Predicting Poor Prognosis and Therapeutic Response in Human Nasopharygeal Carcinoma
por: Yun, Miao, et al.
Publicado: (2015)

Upregulation of Cullin 4B Promotes Gastric Cancer and Predicts Poor Prognosis
por: Wu, Ping, et al.
Publicado: (2020)

Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction
por: Shu, Chin-Chung, et al.
Publicado: (2013)

Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets
por: Kotowski, Krzysztof, et al.
Publicado: (2021)

C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection
por: Sahu, Bikash R., et al.
Publicado: (2020)

A Potential Oncogenic Role for PFKFB3 Overexpression in Gastric Cancer Progression
por: Lei, Lan, et al.
Publicado: (2021)

The influence of PFK-II overexpression on neuroblastoma patients’ survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4
por: Trojan, Sonia E., et al.
Publicado: (2019)

ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer
por: Li, Rongkun, et al.
Publicado: (2017)

Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric Cancer
por: Liu, Fang, et al.
Publicado: (2014)

Sema3C promotes hepatic metastasis and predicts poor prognosis in gastric adenocarcinoma
por: Li, Maoran, et al.
Publicado: (2021)

B7-H4 is Predictive of Poor Prognosis in Patients with Gastric Cancer
por: Cui, YongHui, et al.
Publicado: (2016)

FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics
por: Li, Li, et al.
Publicado: (2019)

SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer
por: Yu, Pengcheng, et al.
Publicado: (2022)

Roles of PFKFB3 in cancer
por: Shi, Linlin, et al.
Publicado: (2017)

FERMT1 promotes gastric cancer progression by activating the NF-κB pathway and predicts poor prognosis
por: Fan, Hua, et al.
Publicado: (2020)

Overexpression of NEK3 is associated with poor prognosis in patients with gastric cancer
por: Cao, Yongfeng, et al.
Publicado: (2018)

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
por: Jin, Jingchun, et al.
Publicado: (2012)

Postoperative fever predicts poor prognosis of gastric cancer
por: Feng, Fan, et al.
Publicado: (2017)

Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis
por: Huang, Chao, et al.
Publicado: (2020)

PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer
por: Li, Xinwei, et al.
Publicado: (2022)

High Hepsin expression predicts poor prognosis in Gastric Cancer
por: Zhang, Mingming, et al.
Publicado: (2016)

IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis
por: Song, Chengcheng, et al.
Publicado: (2022)

High Expression of CEMIP Correlates Poor Prognosis and the Tumur Microenvironment in Breast Cancer as a Promisingly Prognostic Biomarker
por: Dong, Xingxing, et al.
Publicado: (2021)

Elevated Expression of Calpain-4 Predicts Poor Prognosis in Patients with Gastric Cancer after Gastrectomy
por: Peng, Peike, et al.
Publicado: (2016)

Glycolytic regulatory enzyme PFKFB3 as a prognostic and tumor microenvironment biomarker in human cancers
por: Da, Qingen, et al.
Publicado: (2023)

MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial–Mesenchymal Transition In Gastric Cancer
por: Li, Taiyuan, et al.
Publicado: (2019)

CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors
por: Yan, Liang, et al.
Publicado: (2020)

Decreased expression of STING predicts poor prognosis in patients with gastric cancer
por: Song, Shushu, et al.
Publicado: (2017)

High expression of GNB4 predicts poor prognosis in patients with Helicobacter pylori-positive advanced gastric cancer
por: Gao, Jianpeng, et al.
Publicado: (2020)

SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma
por: Zhang, Xin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vs179n6egrdrlgsgrkrn9c78lc